Carnosine
Also known as: beta-alanyl-L-histidine, Carnosine, Ignotine, L-Carnosine, N-beta-alanyl-L-histidine, N‑acetylcarnosine, β‑alanine‑L‑histidine
Source Carnosine at Peptiology
Save 10% with code PEPTI-BOSSRABBIT-10
Tapping Shop Now & Save 10% copies your 10% off code PEPTI-BOSSRABBIT-10 to your clipboard. Paste it at the Peptiology checkout to claim the discount.
Summary
Carnosine (β‑alanine‑L‑histidine) is a naturally occurring dipeptide found in skeletal muscle, brain, and cardiac tissue. It is used as a dietary supplement for its antioxidant and buffering properties and is investigated for anti‑aging, neuroprotective, and metabolic benefits.
Mechanism of Action
Acts as an intracellular pH buffer, antioxidant, metal‑chelator and anti‑glycation agent; modulates calcium handling in muscle and brain tissue.
Routes of Administration
Goals & Uses
- Exercise performance and muscle bufferingAthletic PerformanceModerate
- Anti‑glycationAgingLow
- NeuroprotectionNeurologyLow
- Metabolic syndrome / glycemic controlMetabolic HealthModerate
- Wound healing and skin anti-agingDermatologyLow
- Ocular health (cataracts)OphthalmologyLow
- Antioxidant supportOxidative StressModerate
- pH buffering in muscleExercise PerformanceModerate
- Anti-aging / cellular protectionLongevityLow
Contraindications
- Severe renal impairmentOrganModerateKidney function concerns
- Known hypersensitivity to carnosine or beta-alanineAllergyHigh
- Carnosinemia (carnosinase deficiency)Metabolic DisorderHigh
Adverse Effects
- Gastrointestinal discomfortGastrointestinalUncommon
- Neurological effects in carnosinemiaNeurologicalRare
- Paresthesia / tinglingNeurologicalUncommon
- Hypotension (intravenous)CardiovascularRare
Drug Interactions
- Zinc supplements / zinc-containing compoundsLow
- Antidiabetic agentsLow
- ACE inhibitorsLow
Population Constraints
- Renal impairmentOrgan ImpairmentRelative
- Pediatric populationsAgeRelative
- Pregnant or lactating womenReproductiveRelative
- Pregnancy and lactationReproductiveRelative
Regulatory Status
- European UnionUnapprovedMarketed as a food supplement; no medicinal approval.
- United StatesUnapprovedAvailable as a dietary supplement; not FDA‑approved as a drug.
- United KingdomUnapprovedAvailable OTC as a supplement; no MHRA drug approval.
Classified as a dietary supplement in the United States (not FDA-approved as a drug). Not approved as a pharmaceutical in the EU or UK. Research use in various jurisdictions. L-Carnosine supplements are commercially available OTC worldwide.
Evidence & Sources
No sources recorded yet.
Frequently Asked Questions
What is Carnosine?
Carnosine (β‑alanine‑L‑histidine) is a naturally occurring dipeptide found in skeletal muscle, brain, and cardiac tissue. It is used as a dietary supplement for its antioxidant and buffering properties and is investigated for anti‑aging, neuroprotective, and metabolic benefits.
What is Carnosine used for?
Carnosine is educationally associated with: Exercise performance and muscle buffering, Anti‑glycation, Neuroprotection, Metabolic syndrome / glycemic control, Wound healing and skin anti-aging, Ocular health (cataracts), Antioxidant support, pH buffering in muscle, Anti-aging / cellular protection. Educational only — not medical advice.
How is Carnosine administered?
Recorded routes of administration: Intravenous (investigational), Oral, Topical.
What are the potential side effects of Carnosine?
Reported adverse effects include: Gastrointestinal discomfort, Neurological effects in carnosinemia, Paresthesia / tingling, Hypotension (intravenous). This list is not exhaustive — consult a qualified clinician.
Who should avoid Carnosine?
Recorded contraindications: Severe renal impairment, Known hypersensitivity to carnosine or beta-alanine, Carnosinemia (carnosinase deficiency). Consult a qualified clinician before use.